Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × Zoledronic Acid × Clear all

NCT03358017 2023-10-19

YAPPETIZER

Phase 2 Completed

Triple Negative Breast Neoplasms

NCT04045522 2021-07-20

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms